yes, alnby, the impairment loss taken above the line is one of the factors that accounted for the "20% earnings understatement" that I alluded to earlier.
Then there are also:
- $156k of expenses relating to the executive share plan (pcp: $11k),
- $220k expense for equity-settled, share-based payments (pcp: $66k), and
- $128k of R&D expenses (pcp: $23k).
While there are a few offsets to these directly-expensed imposts (when more aggressive financial directors might have accounted for them in a less punitive fashion), the net effect I estimate to have been close to a negative $1.0m delta on JH14 Pre-tax Profit.
This result is prudential buffer and padding.
It's the way all self-respecting shareholders should want it.
- Forums
- ASX - By Stock
- dividend
yes, alnby, the impairment loss taken above the line is one of...
Featured News
Add KOV (ASX) to my watchlist
|
|||||
Last
$9.65 |
Change
-0.090(0.92%) |
Mkt cap ! $112.6M |
Open | High | Low | Value | Volume |
$9.75 | $9.75 | $9.65 | $133.3K | 13.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 908 | $9.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.75 | 203 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 908 | 9.650 |
1 | 600 | 9.630 |
1 | 2100 | 9.570 |
1 | 1996 | 9.380 |
2 | 337 | 9.350 |
Price($) | Vol. | No. |
---|---|---|
9.750 | 203 | 1 |
9.790 | 580 | 1 |
9.800 | 520 | 1 |
9.900 | 1000 | 1 |
10.000 | 50 | 1 |
Last trade - 14.31pm 26/07/2024 (20 minute delay) ? |
Featured News
KOV (ASX) Chart |